Although cancer negatively impacts almost every family across generations, racial minorities’ experiences with cancer diagnosis, treatment, and insurance coverage are arguably unique. This article assesses the extent to which demographic characteristics predict coverage denial for cancer treatment, and results reveal that among those with cancer, racial minorities are at least twice as likely to be denied coverage for treatment. However, senior citizens, a large majority of whom are supported by Medicare’s clear policies on cancer treatment have lower odds of being denied coverage, suggesting that racial minorities who rely on private insurers may benefit from additional clarity regarding coverage-related benefits.
No takes yet. Share an insight, caveat, or question.
Jamaal Marshall (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: